Panel Discussion: Multiplex IF Panel Design & the Value of Transcriptomics & Protein Detection

Time: 11:50 am
day: Conference Agenda


• Overcoming key barriers to large-scale adoption and application of multiplexed immunofluorescence in clinical settings, can we ever overcome the use of just PD1/PDL1 assays?
• How can multiplex immunofluorescence improve validation of biomarkers in tissue when evaluating clinical utility of compounds of interest?
• Evaluating the reliability of biomarker results across technology types and approaching multi-OMICs datasets
• Discussing the impact of preanalytical variables on biomarker staining